Non-lab and semi-lab algorithms for screening undiagnosed diabetes: A cross-sectional studyResearch in context
Wei Li,
Bo Xie,
Shanhu Qiu,
Xin Huang,
Juan Chen,
Xinling Wang,
Hong Li,
Qingyun Chen,
Qing Wang,
Ping Tu,
Lihui Zhang,
Sunjie Yan,
Kaili Li,
Jimilanmu Maimaitiming,
Xin Nian,
Min Liang,
Yan Wen,
Jiang Liu,
Mian Wang,
Yongze Zhang,
Li Ma,
Hang Wu,
Xuyi Wang,
Xiaohang Wang,
Jingbao Liu,
Min Cai,
Zhiyao wang,
Lin Guo,
Fangqun Chen,
Bei Wang,
Sandberg Monica,
Per-Ola Carlsson,
Zilin Sun
Affiliations
Wei Li
Department of Endocrinology, Zhongda Hospital, Institute of Diabetes, School of Medicine, Southeast Uiversity, Nanjing, China
Bo Xie
Department of Endocrinology, Zhongda Hospital, Institute of Diabetes, School of Medicine, Southeast Uiversity, Nanjing, China
Shanhu Qiu
Department of Endocrinology, Zhongda Hospital, Institute of Diabetes, School of Medicine, Southeast Uiversity, Nanjing, China
Xin Huang
School of Public Health, Southeast University, Nanjing, China
Juan Chen
Department of Endocrinology, Zhongda Hospital, Institute of Diabetes, School of Medicine, Southeast Uiversity, Nanjing, China
Xinling Wang
Department of Endocrinology, People's Hospital of Xinjiang Uyghur Autonomous Region, Urumqi, China
Hong Li
Department of Endocrinology, First Affiliated Hospital of Kunming Medical University, Kunming, China
Qingyun Chen
Department of Endocrinology, The First Affiliated Hospital of Guangxi Medical University, Nanning, China
Qing Wang
Department of Endocrinology, China-Japan Union Hospital of Jilin University, Changchun, China
Ping Tu
Department of Endocrinology, The Third Hospital of Nanchang, Nanchang, China
Lihui Zhang
Department of Endocrinology, The Second Hospital of Hebei Medical University, Shijiazhuang, China
Sunjie Yan
Department of Endocrinology, The First Affiliated Hospital of Fujian Medical University, Diabetes Research Institute of Fujian Province, Fuzhou, China
Kaili Li
Department of Endocrinology, Xinjiang Uygur Autonomous Region Hospital of traditional Chinese Medicine, Urumqi, China
Jimilanmu Maimaitiming
Department of Endocrinology, People's Hospital of Xinjiang Uyghur Autonomous Region, Urumqi, China
Xin Nian
Department of Endocrinology, First Affiliated Hospital of Kunming Medical University, Kunming, China
Min Liang
Department of Endocrinology, The First Affiliated Hospital of Guangxi Medical University, Nanning, China
Yan Wen
Department of Endocrinology, China-Japan Union Hospital of Jilin University, Changchun, China
Jiang Liu
Department of Endocrinology, The Third Hospital of Nanchang, Nanchang, China
Mian Wang
Department of Endocrinology, The Second Hospital of Hebei Medical University, Shijiazhuang, China
Yongze Zhang
Department of Endocrinology, The First Affiliated Hospital of Fujian Medical University, Diabetes Research Institute of Fujian Province, Fuzhou, China
Li Ma
Department of Endocrinology, Xinjiang Uygur Autonomous Region Hospital of traditional Chinese Medicine, Urumqi, China
Hang Wu
Department of Endocrinology, Zhongda Hospital, Institute of Diabetes, School of Medicine, Southeast Uiversity, Nanjing, China
Xuyi Wang
Department of Endocrinology, Zhongda Hospital, Institute of Diabetes, School of Medicine, Southeast Uiversity, Nanjing, China
Xiaohang Wang
Department of Endocrinology, Zhongda Hospital, Institute of Diabetes, School of Medicine, Southeast Uiversity, Nanjing, China
Jingbao Liu
Department of Endocrinology, Zhongda Hospital, Institute of Diabetes, School of Medicine, Southeast Uiversity, Nanjing, China
Min Cai
Department of Endocrinology, Zhongda Hospital, Institute of Diabetes, School of Medicine, Southeast Uiversity, Nanjing, China
Zhiyao wang
Suzhou MetroHealth Medical Technology, Co., LTD, Suzhou, China
Lin Guo
Suzhou MetroHealth Medical Technology, Co., LTD, Suzhou, China
Fangqun Chen
Suzhou MetroHealth Medical Technology, Co., LTD, Suzhou, China
Bei Wang
School of Public Health, Southeast University, Nanjing, China
Sandberg Monica
Department of Medical Cell Biology, Uppsala University, SE-75123 Uppsala, Sweden
Per-Ola Carlsson
Department of Medical Cell Biology, Uppsala University, SE-75123 Uppsala, Sweden; Correspondence to: P. O. Carlsson, Department of Medical Cell Biology, Uppsala University, Uppsala, Sweden.
Zilin Sun
Department of Endocrinology, Zhongda Hospital, Institute of Diabetes, School of Medicine, Southeast Uiversity, Nanjing, China; Correspondence to: Z.L. Sun, Department of Endocrinology, Zhongda Hospital, Institute of Diabetes, School of Medicine, Southeast University, Nanjing, China.
Background: The terrifying undiagnosed rate and high prevalence of diabetes have become a public emergency. A high efficiency and cost-effective early recognition method is urgently needed. We aimed to generate innovative, user-friendly nomograms that can be applied for diabetes screening in different ethnic groups in China using the non-lab or noninvasive semi-lab data. Methods: This multicenter, multi-ethnic, population-based, cross-sectional study was conducted in eight sites in China by enrolling subjects aged 20–70. Sociodemographic and anthropometric characteristics were collected. Blood and urine samples were obtained 2 h following a standard 75 g glucose solution. In the final analysis, 10,794 participants were included and randomized into model development (n = 8096) and model validation (n = 2698) group with a ratio of 3:1. Nomograms were developed by the stepwise binary logistic regression. The nomograms were validated internally by a bootstrap sampling method in the model development set and externally in the model validation set. The area under the receiver operating characteristic curve (AUC) was used to assess the screening performance of the nomograms. Decision curve analysis was applied to calculate the net benefit of the screening model. Results: The overall prevalence of undiagnosed diabetes was 9.8% (1059/10794) according to ADA criteria. The non-lab model revealed that gender, age, body mass index, waist circumference, hypertension, ethnicities, vegetable daily consumption and family history of diabetes were independent risk factors for diabetes. By adding 2 h post meal glycosuria qualitative to the non-lab model, the semi-lab model showed an improved Akaike information criterion (AIC: 4506 to 3580). The AUC of the semi-lab model was statistically larger than the non-lab model (0.868 vs 0.763, P < 0.001). The optimal cutoff probability in semi-lab and non-lab nomograms were 0.088 and 0.098, respectively. The sensitivity and specificity were 76.3% and 81.6%, respectively in semi-lab nomogram, and 72.1% and 67.3% in non-lab nomogram at the optimal cut off point. The decision curve analysis also revealed a bigger decrease of avoidable OGTT test (52 per 100 subjects) in the semi-lab model compared to the non-lab model (36 per 100 subjects) and the existed New Chinese Diabetes Risk Score (NCDRS, 35 per 100 subjects). Conclusion: The non-lab and semi-lab nomograms appear to be reliable tools for diabetes screening, especially in developing countries. However, the semi-lab model outperformed the non-lab model and NCDRS prediction systems and might be worth being adopted as decision support in diabetes screening in China. Keywords: Diabetes, Nomogram, Decision curve, Risk algorithm